Robot vs. camera: which lung cancer surgery is better?
NCT ID NCT02617186
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares two types of minimally invasive lung cancer surgery: robotic-assisted surgery and video-assisted thoracoscopic surgery (VATS). About 446 people with early-stage non-small cell lung cancer will be randomly assigned to one of the two procedures. The main goal is to see if one approach leads to better quality of life 12 weeks after surgery, and also to compare costs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If robotic surgery proves better for quality of life or cost, it could become the preferred minimally invasive option for early-stage lung cancer.
- What could go wrong
- This is a comparative effectiveness study, not a test of a new treatment. Results may show no meaningful difference between the two surgical approaches.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
McMaster University / St. Joseph's Healthcare Hamilton
Hamilton, Ontario, L8N 4A6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?